Home Tools
Log in
Cart

Search Result

Search Results for " immunogenic "

20

Compounds

Cat No. Product Name Synonyms Targets
T7194 CM-272 Apoptosis , DNA Methyltransferase , Histone Methyltransferase
CM-272 is a dual G9a/DNA methyltransferases (DNMTs) inhibitor.
T7022 PEG300 Polyethylene glycol 300 Others
PEG300 (Polyethylene glycol 300) is a polymer formed from repeating units of ethylene glycol that is water soluble, low immunogenicity, and biocompatible. PEG300 is a neutral polymer with a molecular weight of 300.
TP1554L HPV16 E7 (86-93) acetate HPV16 E7 (86-93) acetate(160212-93-1 Free base) Others
HPV16 E7 (86-93) acetate is a derived peptide of human leukocyte antigen A2.1 restricted HPV16 E7 with immunogenic property in cervical carcinomas.
T11855 Lipopolysaccharides LPS Others
Lipopolysaccharides (LPS) is a natural product, an endotoxin derived from the outer leaflet of the outer membrane of Gram-negative bacteria. Lipopolysaccharides are highly immunogenic antigens that enhance the immune res...
T7657L MOG peptide (35-55) , mouse, rat acetate Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate,MOG peptide (35-55) , mouse, rat acetate (149635-73-4 Free base) Others
Myelin Oligodendrocyte Glycoprotein (MOG) peptide (35-55) , mouse, rat acetate is a MOG peptide (35-55) derivative. MOG peptide (35-55) is a part of myelin oligodendrocyte glycoprotein (MOG) immunogenic peptide and can b...
T15003 CP-20961 Others
CP-20961 is a synthetic non-immunogenic adjuvant. It induces arthritis.
T27859 LTX-401 HCl LTX 401,LTX401,LTX-401
LTX-401 is an immunotherapeutic agent and an oncolytic amino acid derivative with potential immunogenic properties.
T33626 Nelipepimut-S NeuVax vaccine,E75 peptide,NeuVax
Nelipepimut-S, as an immunogenic peptide from the HER2 protein, is highly expressed in breast cancer.
T35421 2'-O-Succinyl-cAMP
2'-O-Monosuccinyladenosine-3',5'-cyclic monophosphate is an immunogenic derivative of cAMP that has been used to generate anti-cAMP antisera and antibodies.1,2
T38936 KRAS G13D peptide, 25 mer KRAS G13D peptide, 25 mer
KRAS G13D peptide, a 25-mer sequence, is derived from the KRAS activating oncogene mutation and serves as an immune potentiator. This peptide possesses immunogenic properties and can be utilized for the development of a ...
T82348 GAGGVGKSAL
GAGGVGKSAL, a wild-type KRAS G12D 10mer peptide, serves as an immunogenic neoantigen in cancer immunotherapy research [1].
T82352 GADGVGKSAL
GADGVGKSAL, a mutant KRAS G12D 10mer peptide, serves as an immunogenic neoantigen in cancer immunotherapy research [1].
T82349 GAGGVGKSA
GAGGVGKSA, a wild-type KRAS G12D 9mer peptide, serves as an immunogenic neoantigen pivotal for cancer immunotherapy research [1].
T82353 GADGVGKSA
GADGVGKSA, a mutant KRAS G12D 9mer peptide, serves as an immunogenic neoantigen for cancer immunotherapy research [1].
T83135 Alrefimotide hTERT (660–689)
Alrefimotide, an immunogenic peptide derived from hTERT, possesses the sequence ALFSVLNYERARRPGLLGASVLGLDDIHRA and has applications in cancer immunotherapy research [1].
T76015 HPV16 E7 (86-93) (TFA)
HPV16 E7 (86-93) TFA, a peptide derived from HPV16 E7, is restricted by human leukocyte antigen (HLA)-A2.1 and exhibits immunogenic properties in cervical carcinomas [1] [2].
TP1554 HPV16 E7 (86-93)
This is amino acids 86 to 93 fragment of the human papilloma virus (HPV) type 16 oncoprotein E7. This HPV16-encoded peptide has very high affinity of binding to the HLA-A*0201 molecule.This immunogenic fragment may be us...
T39110 MOG (35-55), human
MOG (35-55), human, a constituent of central nervous system myelin, is distinguishable from mMOG (35-55) due to a proline-to-serine substitution at position 42. It possesses immunogenic properties and is partially cross-...
T36996 MSA-2 dimer
MSA-2 dimer, a selective and orally active non-nucleotide STING agonist with a dissociation constant (Kd) of 145 μM, demonstrates prolonged antitumor and immunogenic activity. It non-covalently binds to STING as a dimer,...
T73544 MPM-1
MPM-1, a mimic of marine Eusynstyelamides, serves as an effective anticancer agent. It swiftly induces a necrosis-like death in cancer cells in vitro, facilitates immunogenic cell death, and disrupts autophagy, leading t...
1 2
TargetMol